Literature DB >> 32167527

Towards precision disease-modelling in experimental myocarditis.

Alexandros Protonotarios1,2,3, Federica Marelli-Berg1,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32167527      PMCID： PMC7380721          DOI： 10.1093/cvr/cvaa057

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  11 in total

1.  Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.

Authors:  S Tracy; K Höfling; S Pirruccello; P H Lane; S M Reyna; C J Gauntt
Journal:  J Med Virol       Date:  2000-09       Impact factor: 2.327

2.  Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.

Authors:  M S Horwitz; A La Cava; C Fine; E Rodriguez; A Ilic; N Sarvetnick
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

Review 3.  Myocarditis: current trends in diagnosis and treatment.

Authors:  Jared W Magnani; G William Dec
Journal:  Circulation       Date:  2006-02-14       Impact factor: 29.690

4.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Alida L P Caforio; Sabine Pankuweit; Eloisa Arbustini; Cristina Basso; Juan Gimeno-Blanes; Stephan B Felix; Michael Fu; Tiina Heliö; Stephane Heymans; Roland Jahns; Karin Klingel; Ales Linhart; Bernhard Maisch; William McKenna; Jens Mogensen; Yigal M Pinto; Arsen Ristic; Heinz-Peter Schultheiss; Hubert Seggewiss; Luigi Tavazzi; Gaetano Thiene; Ali Yilmaz; Philippe Charron; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-07-03       Impact factor: 29.983

5.  Cardiac, pancreatic, and liver abnormalities in a patient with coxsackie-B infection.

Authors:  N L Coplan; V Atallah; S Mediratta; M S Bruno; N P DePasquale
Journal:  Am J Med       Date:  1996-09       Impact factor: 4.965

Review 6.  Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

7.  Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.

Authors:  Sandra Pinkert; Markian Pryshliak; Kathleen Pappritz; Klaus Knoch; Ahmet Hazini; Babette Dieringer; Katrin Schaar; Fengquan Dong; Luisa Hinze; Jie Lin; Dirk Lassner; Robert Klopfleisch; Michele Solimena; Carsten Tschöpe; Ziya Kaya; Muhammad El-Shafeey; Antje Beling; Jens Kurreck; Sophie Van Linthout; Karin Klingel; Henry Fechner
Journal:  Cardiovasc Res       Date:  2020-08-01       Impact factor: 10.787

8.  Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis.

Authors:  Nicole L Kallewaard; Lili Zhang; Jin-Wen Chen; Marta Guttenberg; Melissa D Sanchez; Jeffrey M Bergelson
Journal:  Cell Host Microbe       Date:  2009-07-23       Impact factor: 21.023

9.  Acute fulminant, fatal coxsackie B virus infection: a report of two cases.

Authors:  G Lau
Journal:  Ann Acad Med Singap       Date:  1994-11       Impact factor: 2.473

10.  Effusive-constrictive pericarditis, hepatitis, and pancreatitis in a patient with possible coxsackievirus B infection: a case report.

Authors:  Jon Persichino; Roger Garrison; Rajagopal Krishnan; Made Sutjita
Journal:  BMC Infect Dis       Date:  2016-08-08       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.